159 related articles for article (PubMed ID: 1584348)
1. Human glioma-specific antigens detected by monoclonal antibodies.
Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
[TBL] [Abstract][Full Text] [Related]
2. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
Solheid C; Lauro G; Palladini G
J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the close relationship between human astrocytoma-specific antigens detected by murine monoclonal antibodies and c-kit proto-oncogene product.
Kondo S; Miyatake S; Matsumoto M; Nakatsu S; Iwasaki K; Oda Y; Kikuchi H; Namba Y
Biochem Biophys Res Commun; 1992 Jan; 182(2):474-80. PubMed ID: 1370880
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s).
Matsuda M; Fischer DK; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():271-83. PubMed ID: 1805572
[TBL] [Abstract][Full Text] [Related]
5. Serological analysis of tumor antigens in malignant glioma patients.
Yoshida S; Tanaka R; Ono K
Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
[TBL] [Abstract][Full Text] [Related]
6. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
Holladay FP; Lopez G; De M; Morantz RA; Wood GW
Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
[TBL] [Abstract][Full Text] [Related]
9. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against human astrocytomas and their reactivity pattern.
Stavrou D; Keiditsch E; Schmidberger F; Bise K; Funke I; Eisenmenger W; Kurrle R; Martin B; Stocker U
J Neurol Sci; 1987 Sep; 80(2-3):205-20. PubMed ID: 3316507
[TBL] [Abstract][Full Text] [Related]
11. Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
Vrionis FD; Wikstrand CJ; Bigner DD
Ann N Y Acad Sci; 1988; 540():64-77. PubMed ID: 2462837
[No Abstract] [Full Text] [Related]
12. Characterization of human gliomas by a monoclonal antibody both on tissue culture and paraffin-embedded sections.
Sipos L; Wakabayashi T; Szeifert GT; Fazekas I; Afra D
Neurol Res; 1992 Jun; 14(3):263-6. PubMed ID: 1355282
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigen.
Klaich GM; Kanter PM
Anticancer Drugs; 1995 Feb; 6(1):45-52. PubMed ID: 7756683
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
[TBL] [Abstract][Full Text] [Related]
15. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
16. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
[TBL] [Abstract][Full Text] [Related]
17. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
J Hematother; 1995 Oct; 4(5):477-83. PubMed ID: 8581388
[TBL] [Abstract][Full Text] [Related]
18. [Reactivity of monoclonal antibodies ALT-01 and ALT-04 and identification of lung cancer-associated antigens].
Fan MZ; Qiu WR; Yu YB; Chen ZX; Cao SL; Wu RH; Wu H; Zhong JA; Ma YL; Xin YL
Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):161-4, 9. PubMed ID: 3447854
[TBL] [Abstract][Full Text] [Related]
19. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
